🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is to assess the safety and tolerability of TAB004 as...
Status
Unknown
Location
University of Alabama at Birmingham
Start Date
2019-10-30
Trial ID
NCT04137900
Treatments Being Tested
A First-in-human, dose-escalation, dose-expansion phase I clinical study of...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2020-07-17
Trial ID
NCT04477772
This is an open-label phase I study to evaluate the safety, tolerability, a...
Status
Terminated
Location
Chinese PLA General Hospital
Start Date
2022-07-28
Trial ID
NCT05427396
Treatments Being Tested
This is an open-label phase I/II study to evaluate the safety, tolerability...
Status
Completed
Location
Jilin Cancer Hospital
Start Date
2021-08-27
Trial ID
NCT05000684
Treatments Being Tested
This study is A prospective，single arm, multicenter clinical study of BTLA ...
Status
Not Yet Recruiting
Location
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2025-10-30
Trial ID
NCT06730932
This is an open-label phase Ib/II clinical study to evaluate the safety, to...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2023-02-09
Trial ID
NCT05664971